Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Atezolizumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Atezolizumabmarket, defines the market attractiveness level of Atezolizumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Atezolizumab industry, describes the types of Atezolizumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Atezolizumab market and the development prospects and opportunities of Atezolizumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Atezolizumab market in Chapter 13.
By Player:
Genentech (Roche)
By Type:
Single Drug
Chemotherapy Combination
By End-User:
Bladder Cancer
Lung Cancer
Advanced Triple-negative Breast Cancer
Head and Neck Cancer
Urothelial Carcinoma
Renal Cell Carcinoma
Hepatocellular Carcinoma (HCC)
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Atezolizumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Atezolizumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Atezolizumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Atezolizumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Atezolizumab Market Analysis and Outlook to 2022
-
7.1 Global Atezolizumab Consumption (2017-2022)
-
7.2 United States Atezolizumab Consumption (2017-2022)
-
7.3 Europe Atezolizumab Consumption (2017-2022)
-
7.4 China Atezolizumab Consumption (2017-2022)
-
7.5 Japan Atezolizumab Consumption (2017-2022)
-
7.6 India Atezolizumab Consumption (2017-2022)
-
7.7 South Korea Atezolizumab Consumption (2017-2022)
8 Region and Country-wise Atezolizumab Market Analysis and Outlook to 2028
-
8.1 Global Atezolizumab Consumption Forecast (2022-2028)
-
8.2 United States Atezolizumab Consumption Forecast (2022-2028)
-
8.3 Europe Atezolizumab Consumption Forecast (2022-2028)
-
8.4 China Atezolizumab Consumption Forecast (2022-2028)
-
8.5 Japan Atezolizumab Consumption Forecast (2022-2028)
-
8.6 India Atezolizumab Consumption Forecast (2022-2028)
-
8.7 South Korea Atezolizumab Consumption Forecast (2022-2028)
9 Global Atezolizumab Market Outlook by Types and Applications to 2022
-
9.1 Global Atezolizumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Single Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Combination Consumption and Growth Rate (2017-2022)
-
9.2 Global Atezolizumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Advanced Triple-negative Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Head and Neck Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Urothelial Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Renal Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Hepatocellular Carcinoma (HCC) Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Other Consumption and Growth Rate (2017-2022)
10 Global Atezolizumab Market Outlook by Types and Applications to 2028
-
10.1 Global Atezolizumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Single Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Combination Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Atezolizumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Advanced Triple-negative Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Head and Neck Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Urothelial Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Renal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Hepatocellular Carcinoma (HCC) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Atezolizumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Atezolizumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Atezolizumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Atezolizumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Atezolizumab Market Competitive Analysis
-
14.1 Genentech (Roche)
-
14.1.1 Genentech (Roche) Company Details
-
14.1.2 Genentech (Roche) Atezolizumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Genentech (Roche) Atezolizumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Atezolizumab
-
Figure Atezolizumab Picture
-
Table Global Atezolizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Atezolizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Atezolizumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Atezolizumab Consumption by Country (2017-2022)
-
Figure United States Atezolizumab Consumption and Growth Rate (2017-2022)
-
Table Europe Atezolizumab Consumption and Growth Rate (2017-2022)
-
Figure China Atezolizumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Atezolizumab Consumption and Growth Rate (2017-2022)
-
Figure India Atezolizumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Atezolizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Atezolizumab Consumption Forecast by Country (2022-2028)
-
Figure United States Atezolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Atezolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Atezolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Atezolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Atezolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Atezolizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Combination Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Advanced Triple-negative Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Head and Neck Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Urothelial Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatocellular Carcinoma (HCC) Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Single Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Combination Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Advanced Triple-negative Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head and Neck Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urothelial Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatocellular Carcinoma (HCC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Atezolizumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Atezolizumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Genentech (Roche) (Foundation Year, Company Profile and etc.)
-
Table Genentech (Roche) Atezolizumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Atezolizumab Product and Service
-
